19-12897793-G-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_000159.4(GCDH):c.1173G>T(p.Gly391Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.351 in 1,612,912 control chromosomes in the GnomAD database, including 103,534 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.31 ( 7709 hom., cov: 30)
Exomes 𝑓: 0.36 ( 95825 hom. )
Consequence
GCDH
NM_000159.4 synonymous
NM_000159.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.11
Publications
27 publications found
Genes affected
GCDH (HGNC:4189): (glutaryl-CoA dehydrogenase) The protein encoded by this gene belongs to the acyl-CoA dehydrogenase family. It catalyzes the oxidative decarboxylation of glutaryl-CoA to crotonyl-CoA and CO(2) in the degradative pathway of L-lysine, L-hydroxylysine, and L-tryptophan metabolism. It uses electron transfer flavoprotein as its electron acceptor. The enzyme exists in the mitochondrial matrix as a homotetramer of 45-kD subunits. Mutations in this gene result in the metabolic disorder glutaric aciduria type 1, which is also known as glutaric acidemia type I. Alternative splicing of this gene results in multiple transcript variants. A related pseudogene has been identified on chromosome 12. [provided by RefSeq, Mar 2013]
GCDH Gene-Disease associations (from GenCC):
- glutaryl-CoA dehydrogenase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet, G2P, Myriad Women’s Health
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 19-12897793-G-T is Benign according to our data. Variant chr19-12897793-G-T is described in ClinVar as Benign. ClinVar VariationId is 92529.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.11 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.383 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GCDH | NM_000159.4 | c.1173G>T | p.Gly391Gly | synonymous_variant | Exon 11 of 12 | ENST00000222214.10 | NP_000150.1 | |
| GCDH | NM_013976.5 | c.1173G>T | p.Gly391Gly | synonymous_variant | Exon 11 of 12 | NP_039663.1 | ||
| GCDH | NR_102316.1 | n.1336G>T | non_coding_transcript_exon_variant | Exon 11 of 12 | ||||
| GCDH | NR_102317.1 | n.1554G>T | non_coding_transcript_exon_variant | Exon 10 of 11 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.307 AC: 46581AN: 151716Hom.: 7691 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
46581
AN:
151716
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.330 AC: 83034AN: 251404 AF XY: 0.328 show subpopulations
GnomAD2 exomes
AF:
AC:
83034
AN:
251404
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.355 AC: 519119AN: 1461078Hom.: 95825 Cov.: 35 AF XY: 0.352 AC XY: 255790AN XY: 726844 show subpopulations
GnomAD4 exome
AF:
AC:
519119
AN:
1461078
Hom.:
Cov.:
35
AF XY:
AC XY:
255790
AN XY:
726844
show subpopulations
African (AFR)
AF:
AC:
6330
AN:
33462
American (AMR)
AF:
AC:
19740
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
AC:
7399
AN:
26134
East Asian (EAS)
AF:
AC:
5173
AN:
39696
South Asian (SAS)
AF:
AC:
23422
AN:
86248
European-Finnish (FIN)
AF:
AC:
16372
AN:
53388
Middle Eastern (MID)
AF:
AC:
1719
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
418806
AN:
1111292
Other (OTH)
AF:
AC:
20158
AN:
60374
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
19103
38206
57309
76412
95515
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
13050
26100
39150
52200
65250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.307 AC: 46632AN: 151834Hom.: 7709 Cov.: 30 AF XY: 0.303 AC XY: 22507AN XY: 74198 show subpopulations
GnomAD4 genome
AF:
AC:
46632
AN:
151834
Hom.:
Cov.:
30
AF XY:
AC XY:
22507
AN XY:
74198
show subpopulations
African (AFR)
AF:
AC:
8352
AN:
41424
American (AMR)
AF:
AC:
5959
AN:
15226
Ashkenazi Jewish (ASJ)
AF:
AC:
986
AN:
3468
East Asian (EAS)
AF:
AC:
750
AN:
5156
South Asian (SAS)
AF:
AC:
1269
AN:
4800
European-Finnish (FIN)
AF:
AC:
3130
AN:
10576
Middle Eastern (MID)
AF:
AC:
88
AN:
294
European-Non Finnish (NFE)
AF:
AC:
25077
AN:
67884
Other (OTH)
AF:
AC:
677
AN:
2100
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1533
3066
4600
6133
7666
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
470
940
1410
1880
2350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
870
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Glutaric aciduria, type 1 Benign:4
Nov 19, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Jun 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not specified Benign:3
Aug 13, 2018
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:3
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Feb 16, 2016
Mayo Clinic Laboratories, Mayo Clinic
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Elevated circulating glutaric acid concentration Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.